EquityZen Growth Technology Fund II LLC - Series 31
Raised
$4M
Investors
4
Min Invest
$320,243
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 31 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett under Rule 506(b) and Section 3(c). The entity raised $4.4M from 4 investors with a $320K minimum investment. This is part of the EquityZen platform, which operates approximately 150 related investment vehicles focused on private equity and secondary market transactions.
This pooled investment fund uses the common 506(b) exemption with a $320K minimum, positioning it in the high-net-worth accredited investor tier typical of institutional-quality private equity vehicles. The series structure and exemption pattern align with single-company or concentrated SPV strategies prevalent in secondary market platforms targeting late-stage private companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
